FDA authorizes use of bivalent mRNA COVID-19 vaccines, monovalent rescinded
SILVER SPRING, MD, April 18, 2023—The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the
Read MoreSILVER SPRING, MD, April 18, 2023—The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the
Read MoreCAMBRIDGE, MA, August 27, 2022—Moderna, Inc., a $53.5 billion biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, filed patent
Read MoreFor the majority of Americans — honestly, for most people globally — the pandemic has been difficult financially: loss of
Read MoreSILVER SPRINGS, MD, November 19, 2021 – Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA)
Read MoreLYNNWOOD, Wash., October 3, 2021 – From the same pandemic that sent the jobless rate to 20.2% in Snohomish County
Read MoreATLANTA, Ga., May 14, 2021 – Today the Center of Disease Control and Prevention (CDC) released findings from its real-world
Read More